Diametrics Medical (US) reports increasing sales:
This article was originally published in Clinica
Diametrics Medical (US) has reported significant sales of its blood test kits in the fourth quarter of 1994. Preliminary year end sales were $331,000 and fourth quarter sales $235,000 compared with $50,000 in the third quarter. The St Paul, Minnesota-based company also says it has reached an agreement in principle to supply its IRMA blood analysis system to Vencor hospitals.
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.